DK8789D0 - Fremgangsmaade til fremstilling af modificerede, staerkt afsvaekkede rna-virusstammer samt vaccine og dens anvendelse - Google Patents

Fremgangsmaade til fremstilling af modificerede, staerkt afsvaekkede rna-virusstammer samt vaccine og dens anvendelse

Info

Publication number
DK8789D0
DK8789D0 DK008789A DK8789A DK8789D0 DK 8789 D0 DK8789 D0 DK 8789D0 DK 008789 A DK008789 A DK 008789A DK 8789 A DK8789 A DK 8789A DK 8789 D0 DK8789 D0 DK 8789D0
Authority
DK
Denmark
Prior art keywords
vaccine
stems
procedure
modified
preparation
Prior art date
Application number
DK008789A
Other languages
English (en)
Other versions
DK8789A (da
Inventor
Carolyn Louise Weeks-Levy
Steven Joseph Mento
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of DK8789D0 publication Critical patent/DK8789D0/da
Publication of DK8789A publication Critical patent/DK8789A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/125—Picornaviridae, e.g. calicivirus
    • A61K39/13—Poliovirus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Physical Deposition Of Substances That Are Components Of Semiconductor Devices (AREA)
DK008789A 1988-01-11 1989-01-10 Fremgangsmaade til fremstilling af modificerede, staerkt afsvaekkede rna-virusstammer samt vaccine og dens anvendelse DK8789A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14250788A 1988-01-11 1988-01-11

Publications (2)

Publication Number Publication Date
DK8789D0 true DK8789D0 (da) 1989-01-10
DK8789A DK8789A (da) 1989-07-12

Family

ID=22500099

Family Applications (1)

Application Number Title Priority Date Filing Date
DK008789A DK8789A (da) 1988-01-11 1989-01-10 Fremgangsmaade til fremstilling af modificerede, staerkt afsvaekkede rna-virusstammer samt vaccine og dens anvendelse

Country Status (9)

Country Link
EP (1) EP0325768B1 (da)
JP (1) JPH01222774A (da)
AT (1) ATE121779T1 (da)
AU (1) AU2833789A (da)
DE (1) DE3853672T2 (da)
DK (1) DK8789A (da)
ES (1) ES2070846T3 (da)
FI (1) FI890116A7 (da)
IL (1) IL88731A0 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5286640A (en) * 1988-01-05 1994-02-15 Almond Jeffrey W Attenuated polioviruses
US5298416A (en) * 1989-01-18 1994-03-29 British Technology Group Ltd. Attenuated polioviruses
GB8901093D0 (en) * 1989-01-18 1989-03-15 Almond Jeffrey W Attenuated viruses
DE68925356T2 (de) * 1989-06-08 1996-09-05 American Cyanamid Co Nicht-zurückmutierende RNA-Viren
GB9107552D0 (en) * 1991-04-10 1991-05-29 Macadam Andrew J Attenuated viruses
GB9107563D0 (en) * 1991-04-10 1991-05-29 Macadam Andrew J Thermostable viruses
GB9705669D0 (en) * 1997-03-19 1997-05-07 British Tech Group Attenuated polioviruses
US6853093B2 (en) 2002-12-20 2005-02-08 Lipman Electronic Engineering Ltd. Anti-tampering enclosure for electronic circuitry
US8405506B2 (en) 2010-08-02 2013-03-26 Verifone, Inc. Secure data entry device
US8593824B2 (en) 2010-10-27 2013-11-26 Verifone, Inc. Tamper secure circuitry especially for point of sale terminal

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4719177A (en) * 1981-04-20 1988-01-12 Massachusetts Institute Of Technology Production of complementary DNA representing RNA viral sequences by recombinant DNA methods and uses therefor
JPS59173084A (ja) * 1982-11-30 1984-09-29 インステイチユ−ト・パスツ−ル ポリオウイルスの免疫原性部位よりなるペプチド類及びこれらのペプチド類を暗合化するヌクレオチド配列を含有するｄｎａ類
EP0156299A3 (en) * 1984-03-26 1987-04-01 Chiron Corporation Ltr modified viral vaccines

Also Published As

Publication number Publication date
EP0325768B1 (en) 1995-04-26
EP0325768A3 (en) 1989-08-30
ATE121779T1 (de) 1995-05-15
DE3853672D1 (de) 1995-06-01
FI890116L (fi) 1989-07-12
JPH01222774A (ja) 1989-09-06
AU2833789A (en) 1989-07-13
IL88731A0 (en) 1989-07-31
DK8789A (da) 1989-07-12
ES2070846T3 (es) 1995-06-16
FI890116A0 (fi) 1989-01-10
DE3853672T2 (de) 1996-01-11
EP0325768A2 (en) 1989-08-02
FI890116A7 (fi) 1989-07-12

Similar Documents

Publication Publication Date Title
ATE85622T1 (de) Chimarenglykoproteine, enthaltend immunogene segmente des humanen respiratorischen synzytialvirus.
EP1504112A4 (en) DEVELOPMENT OF PREVENTIVE VACCINE AGAINST FILOVIRUS INFECTION IN PRIMATES
ES2061500T5 (es) Diagnosis y vacunas de la hepatitis delta, su preparacion y uso.
DE3278344D1 (en) Stabilization of influenza virus vaccine
KR970009347B1 (en) Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3
EP0232798A3 (en) Pseudorabies virus mutants, vaccines containing same, methods for the production of same and methods for the use of same
IT8122814A0 (it) Saggio e vaccino per epatite non-a, non-b.
NO912825D0 (no) Fremgangsmaate for fremstilling av cokonjugate vaksiner omfattende immunogenisk protein, hiv-beslektede peptider og anioniske grupper.
DK8789A (da) Fremgangsmaade til fremstilling af modificerede, staerkt afsvaekkede rna-virusstammer samt vaccine og dens anvendelse
AU580059B2 (en) Vaccine against rabies and preparation process thereof
TW377373B (en) Recombinant raccoon pox viruses and their use as an effective vaccine against feline infectious peritonitis virus disease
ES2130189T3 (es) Vacunas de virus sincitial respiratorio (rsv) mutante que contienen dicho virus y procedimientos de uso.
DK0404625T3 (da) Oligonukleotidsekvenser til amplifikation af genomer af retrovirus af HIV-2 og SIV-typen samt deres anvendelser til in vitro-diagnose af infektioner forårsaget af disse virus
IE780360L (en) Vaccine against "egg drop disease".
LU91152I2 (fr) étanique, d'anatoxine coquelucheuse, d'hémagglutinCombinaison d'anatoxine diphtérique, d'anatoxine tine filamenteuse, de pertactine et de virus poliomyélitique inactivé type 1, type 2 et type 3.
AR242057A1 (es) Poliovirus quimerico viable, cdna recombinante hibrido apto para su produccion en un cultivo de celulas, y procedimiento para la obtencion de dicho poliovirus.
DK56389A (da) Forhindring og behandling af retroviralt frembragte sygdomme
FI893346A0 (fi) Icke-reverterande rna-virus.
DK467181A (da) Virusmutant af shv, vaccine indeholdende denne mutant og fremgangsmaade til fremstilling af vaccinen
RU2006118106A (ru) Вектор химерного аденовируса типа 5/типа 35

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment